These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7785889)

  • 1. Regulation and function of osteopontin in ras-transformed cells.
    Chambers AF
    Ann N Y Acad Sci; 1995 Apr; 760():101-8. PubMed ID: 7785889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions.
    Xuan JW; Hota C; Shigeyama Y; D'Errico JA; Somerman MJ; Chambers AF
    J Cell Biochem; 1995 Apr; 57(4):680-90. PubMed ID: 7542253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin.
    Chambers AF; Hota C; Prince CW
    Cancer Res; 1993 Feb; 53(3):701-6. PubMed ID: 8425206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.
    Chambers AF; Behrend EI; Wilson SM; Denhardt DT
    Anticancer Res; 1992; 12(1):43-7. PubMed ID: 1567180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell.
    Guo X; Zhang YP; Mitchell DA; Denhardt DT; Chambers AF
    Mol Cell Biol; 1995 Jan; 15(1):476-87. PubMed ID: 7799957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.
    Behrend EI; Craig AM; Wilson SM; Denhardt DT; Chambers AF
    Cancer Res; 1994 Feb; 54(3):832-7. PubMed ID: 8306346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene.
    Wu Y; Denhardt DT; Rittling SR
    Br J Cancer; 2000 Jul; 83(2):156-63. PubMed ID: 10901364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin at the tumor/host interface. Functional regulation by thrombin-cleavage and consequences for cell adhesion.
    Senger DR; Brown LF; Perruzzi CA; Papadopoulos-Sergiou A; Van de Water L
    Ann N Y Acad Sci; 1995 Apr; 760():83-100. PubMed ID: 7540380
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
    Zhu Y; Denhardt DT; Cao H; Sutphin PD; Koong AC; Giaccia AJ; Le QT
    Oncogene; 2005 Sep; 24(43):6555-63. PubMed ID: 16007184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
    Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
    Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras-responsive genes and tumor metastasis.
    Chambers AF; Tuck AB
    Crit Rev Oncog; 1993; 4(2):95-114. PubMed ID: 8420573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different patterns of gene expression in ras-resistant and ras-sensitive cells.
    Tuck AB; Wilson SM; Khokha R; Chambers AF
    J Natl Cancer Inst; 1991 Apr; 83(7):485-91. PubMed ID: 1848638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin.
    Bautista DS; Xuan JW; Hota C; Chambers AF; Harris JF
    J Biol Chem; 1994 Sep; 269(37):23280-5. PubMed ID: 8083234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: enhanced expression in H-ras-transformed 3T3 cells.
    Craig AM; Nemir M; Mukherjee BB; Chambers AF; Denhardt DT
    Biochem Biophys Res Commun; 1988 Nov; 157(1):166-73. PubMed ID: 3058125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts.
    Gardner HA; Berse B; Senger DR
    Oncogene; 1994 Aug; 9(8):2321-6. PubMed ID: 8036014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of antisense osteopontin RNA in metastatic mouse fibroblasts is associated with reduced malignancy.
    Behrend EI; Craig AM; Wilson SM; Denhardt DT; Chambers AF
    Ann N Y Acad Sci; 1995 Apr; 760():299-301. PubMed ID: 7785904
    [No Abstract]   [Full Text] [Related]  

  • 19. Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter.
    Denhardt DT; Mistretta D; Chambers AF; Krishna S; Porter JF; Raghuram S; Rittling SR
    Clin Exp Metastasis; 2003; 20(1):77-84. PubMed ID: 12650610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
    Chang PL; Chambers AF
    J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.